DJIA 17,456.62 16.03 0.09%
NASDAQ 5,026.82 -12.96 -0.26%
S&P 500 2,071.07 3.43 0.17%
market minute promo

Novo Nordisk (NYSE: NVO)

57.98 0.34 (0.59%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVO $57.98 0.59%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.22
Previous Close $57.64
Daily Range $57.96 - $58.29
52-Week Range $41.72 - $59.37
Market Cap $153.6B
P/E Ratio 0.00
Dividend (Yield) $0.73 (0.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 178,666
Average Daily Volume 1,219,929
Current FY EPS $1.89




Drug Makers

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website:

News & Commentary Rss Feed

Is This Novo Nordisk's Next Blockbuster Drug?

Novo recently presented terrific data on its pipeline drug IDegLira, but U.S. approval is still far from certain. If it can gain approval, will it be meaningful to the company?

Arena: Sales Flat Again- Belviq Still Losing Market Share

The Weekender

Novo Nordisk A/S (NVO) Hits New Lifetime High

5 NYSE Healthcare Stocks With The Highest ROI

MannKind's Afrezza: An Expensive Failure

Novo Nordisk Up on Positive Results from Diabetes Study - Analyst Blog

Novo Nordisk A/S (NVO) Hits New Lifetime High

Premarket Biotech Digest: Is Gilead Undervalued, Oncolytics' Reolysin, Novo Nordisk Reports Results

Orphan Drugs Series: Time From ODD To Market Approval

Versartis (VSAR) Up on Partial Hold Lift on Lead Candidate - Analyst Blog

See More NVO News...

NVO's Top Competitors

NVO $57.98 (0.59%)
Current stock: NVO
JNJ $98.66 (0.39%)
Current stock: JNJ
NVS $101.90 (0.35%)
Current stock: NVS
RHHBY $35.62 (0.06%)
Current stock: RHHBY